Arbutus Biopharma Corp <ABUS.OQ> expected to post a loss of 10 cents a share - Earnings Preview
Arbutus Biopharma Corp ABUS.OQ ABUS.O is expected to show a rise in quarterly revenue when it reports results on April 30 (estimated) for the period ending March 31 2025
The Warminster Pennsylvania-based company is expected to report a 16.1% increase in revenue to $1.779 million from $1.53 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.
LSEG's mean analyst estimate for Arbutus Biopharma Corp is for a loss of 10 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Arbutus Biopharma Corp is $5.00, above its last closing price of $3.29.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Dec. 31 2024 | -0.08 | -0.07 | Beat | 12.5 | |
Sep. 30 2024 | -0.09 | -0.09 | -0.09 | Met | 4.9 |
Jun. 30 2024 | -0.09 | -0.10 | -0.11 | Missed | -13.6 |
Mar. 31 2024 | -0.11 | -0.11 | -0.10 | Beat | 9.1 |
Dec. 31 2023 | -0.12 | -0.12 | -0.12 | Met | -1.7 |
Sep. 30 2023 | -0.11 | -0.11 | -0.12 | Missed | -5.4 |
Jun. 30 2023 | -0.11 | -0.11 | -0.10 | Beat | 10.9 |
Mar. 31 2023 | -0.14 | -0.14 | -0.10 | Beat | 26.5 |
This summary was machine generated April 28 at 11:41 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Related Articles
Coca Cola (KO) Q4 Earnings Preview: Look for the Upside in the AI Initiatives, not in the Revenue and the EPS
Coca-Cola (KO) enters its fourth-quarter 2025 earnings call tomorrow with significant momentum. However, a fundamental shift is occurring.
Warsh’s Fed Era Signals a Death Knell for QE, Jolting the $30 Trillion Treasury Market
With Warsh’s nomination, his past proposals for governing the Federal Reserve are being brought to the forefront. A central issue is the formulation of a new "1951 Accord" to restructure the relationship between the Fed and the Treasury. Analysts suggest such a move could impact the $30 trillion Tre
Amazon Stock Predictions for 2026 to 2030: Will They Exceed Expectations and Achieve Major Long-Term Goals?
TradingKey - As we head into 2026, many investors are questioning where Amazon (AMZN) fits into the technology world.
A Crash After a Surge: Why Silver Lost 40% in a Week?
TradingKey - Spot silver (XAGUSD) prices continue to decline. Silver plunged 20% on Thursday, breaking below $71 per ounce, with the sell-off intensifying on Friday as prices fell further below $64. Compared to the all-time high set on January 29, silver prices have retraced more than 40%, wiping out nearly all gains accumulated over the previous month.
